tiprankstipranks

Joseph Mollica Insider Profile

4 Followers
Joseph Mollica, Director at Neurocrine, holds 19.18K shares in Neurocrine (Ticker: NBIX), holds 0.00 shares in Celator Pharmaceuticals (Ticker: CLPM).
tipranks
Joseph Mollica

Joseph Mollica
Neurocrine (NBIX)
Director

Not Ranked
Joseph Mollica has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Joseph Mollica's holdings

Insider Roles

Neurocrine
(NBIX)
Director
Roles that Joseph Mollica holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Joseph Mollica

Joseph Mollica's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Neurocrine
Apr 13, 2017
Director
Uninformative Sell
67.96K
$1.83M
CLPM
Celator Pharmaceuticals
$0.00
List of latest transactions for each holding click on a transaction to see Joseph Mollica's performance on stock

Joseph Mollica insider profile FAQ

What is the percentage of profitable transactions made by Joseph Mollica?
The percentage of profitable transactions made by Joseph Mollica is ―.
    What is the average return per transaction made by Joseph Mollica?
    The average return per transaction made by Joseph Mollica is ―.
      What stocks does Joseph Mollica hold?
      Joseph Mollica holds: NBIX, CLPM stocks.
        What was Joseph Mollica’s latest transaction?
        Joseph Mollica latest transaction was an Uninformative Sell of $67.96K.
          What was Joseph Mollica's most profitable transaction?
          Joseph Mollica’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Joseph Mollica's role in Neurocrine?
            Joseph Mollica's role in Neurocrine is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.